Close

Publications

PIOT, P; LARSON, HJ; O'Brien, KL; N'kengasong, J; NG, E; Sow, S; KAMPMANN, B;
2019
Nature, (2019).575 7781 10.1038/s41586-019-1656-7.
Gostin, LO; Hodge, JG; Bloom, BR; El-Mohandes, A; Fielding, J; Hotez, P; Kurth, A; LARSON, HJ; Orenstein, WA; Rabin, K; Ratzan, SC; Salmon, D;
2019
The Lancet. Infectious diseases, (2019).20 1 10.1016/s1473-3099(19)30558-4.
STOCKDALE, L; NASH, S; FARMER, R; RAYNES, J; Mallikaarjun, S; NEWTON, R; FLETCHER, HA;
2019
The Journal of infectious diseases, (2019).221 7 10.1093/infdis/jiz581.
Mathematical modelling of the epidemiological impact, budget impact and cost-effectiveness of novel tuberculosis vaccines on multidrug-resistant tuberculosis [Oral Presentation].
WEERASURIYA, C; Harris, R; BOZZANI, F; Gomez, GB; WHITE, R;
2019
International Journal of Tuberculosis and Lung Disease, (2019).23 10
Sturkenboom, M; Bahri, P; Chiucchiuini, A; Grove Krause, T; Hahné, S; Khromava, A; Kokki, M; Kramarz, P; Kurz, X; LARSON, HJ; De Lusignan, S; Mahy, P; Torcel-Pagnon, L; Titievsky, L; Bauchau, V; ADVANCE consortium,;
2019
Vaccine, (2019).38 Sup, 10.1016/j.vaccine.2019.07.081.
How might novel vaccines for prevention of Tuberculosis disease impact multi-drug resistant tuberculosis burden? A mathematical modelling-based analysis of epidemiologic and health economic impact.
WEERASURIYA, C; Harris, R; SUMNER, T; MCQUAID, C; BOZZANI, F; Knight, G; Gomez, G; WHITE, R;
2019
(2019).
SCHMIDT, W-P; Devamani, CS; Rose, W; ALEXANDER, N; Prakash, JA J;
2019
Tropical Medicine & International Health, (2019).24 12 10.1111/tmi.13322.
CHAN, Y-WD; EDMUNDS, WJ; Chan, H-L; Wong, M-L; Au, K-WA; Chuang, S-K; Van Hoek, AJ; FLASCHE, S;
2019
Human vaccines & immunotherapeutics, (2019).16 3 10.1080/21645515.2019.1663121.